Abstract
ObjectivesThe Sjögren’s syndrome (SS) is a chronic autoimmune disease that affects salivation and consequently the health of oral tissues. The aim of this systematic review was to investigate the implant survival rate, marginal bone loss (MBL) and biological complications of dental implants in SS patients.Materials and methodsEligibility criteria included prospective and retrospective cohort studies, controlled clinical trials, and randomized clinical trials (RCTs). An electronic search without date or language restrictions was carried out in MEDLINE, Cochrane, Web of Science, and LILACS until June 2017. In addition, manual search and in the grey literature were also conducted. The search process, data analysis, and quality assessment were performed by two independent reviewing authors. The protocol of this systematic review was registered in PROSPERO under number CRD42016053277.ResultsThe search and selection process yielded 6 studies, published between 1997 and 2016. An average of 93.7% survival in a mean period of 3.97 years of follow-up was observed. A low number of MBL and biological complications were reported by the studies. All the studies analyzed observed an improvement in life quality of subjects with SS and rehabilitated through dental implants.ConclusionsWith the limitations of this review and based on the available data, the dental implant therapy in SS patients seems to present high implant survival rate, low MBL and low biological complications. In addition, all included studies observed an increase in the quality of life of SS patients who were rehabilitated through dental implants.
Highlights
The use of dental implants is safe and predictable [1]
A low number of marginal bone loss (MBL) and biological complications were reported by the studies
All included studies observed an increase in the quality of life of s syndrome (SS) patients who were rehabilitated through dental implants
Summary
The use of dental implants is safe and predictable [1]. some local or systemic conditions have been associated to dental implant failures such as low insertion torque, peri-implant disease, smoking, bruxism, diabetes, and bisphosphonates [2,3,4,5,6].The SS is an autoimmune rheumatic disease characterized by focal mononuclear cell infiltration of the salivary and lachrymal glands [7]. The use of dental implants is safe and predictable [1]. Some local or systemic conditions have been associated to dental implant failures such as low insertion torque, peri-implant disease, smoking, bruxism, diabetes, and bisphosphonates [2,3,4,5,6]. The SS is an autoimmune rheumatic disease characterized by focal mononuclear cell infiltration of the salivary and lachrymal glands [7]. SS has been suggested to affect 0.2% to 3.0% of the population [8,9,10]. It predominantly affects women between 40 and 60 years of age, with a 9:1 female/male ratio. Younger individuals and children may be affected [11]
Sign-in/Register to view highlights & summary Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
